hero section gradient
15 handpicked stocks

AI Backbone Stocks Surge on $40B Deal 2025

A group of major tech and investment firms led by BlackRock is acquiring Aligned Data Centers for $40 billion to boost AI and cloud capabilities. This landmark deal highlights the critical need for specialized infrastructure, creating opportunities for companies that build, power, and equip the data centers of the future.

Author avatar

Han Tan | Market Analyst

Published on October 16

Your Basket's Financial Footprint

Interpretation of the basket's market capitalisation and investor takeaways.

Key Takeaways for Investors:
  • Large-cap concentration tends to lower volatility and produce more stable returns, aligning with broad-market performance.
  • Use as a core holding for steady exposure rather than a speculative, high-growth allocation.
  • Expect gradual long-term appreciation; short-term explosive gains are unlikely and not the primary objective.
Total Market Cap
  • NVDA: $4.37T

  • MSFT: $3.82T

  • BLK: $186.52B

  • Other

About This Group of Stocks

1

Our Expert Thinking

The $40 billion acquisition of Aligned Data Centers by a BlackRock-led consortium validates the critical importance of AI infrastructure. This massive investment signals that specialized data centres are essential for powering the next generation of artificial intelligence and cloud computing, creating opportunities across the entire value chain.

2

What You Need to Know

This group focuses on companies that build, power, and equip the data centres of the future. From semiconductor manufacturers to networking equipment providers, these firms are positioned to benefit from the accelerating expansion of AI-focused facilities as demand for specialized infrastructure continues to grow.

3

Why These Stocks

These companies were handpicked based on their strategic positioning within the AI infrastructure ecosystem. Each plays a vital role in supporting the physical backbone required for artificial intelligence, from hardware manufacturing to facility construction and operation, offering thematic exposure to this high-growth sector.

Why You'll Want to Watch These Stocks

🚀

Massive Capital Injection

The $40 billion acquisition validates the critical importance of AI infrastructure, signalling sustained investment and growth across the entire ecosystem.

Essential Infrastructure Demand

As AI capabilities expand, the need for specialized data centres, chips, and networking equipment becomes increasingly urgent and profitable.

🎯

Industry Giants Leading

With BlackRock, Nvidia, and Microsoft backing this infrastructure build-out, these companies are positioned at the centre of a transformative trend.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Airbus has cut its delivery targets after discovering a significant fuselage flaw in its A320 aircraft, causing production delays and requiring widespread inspections. This situation could create a significant opening for its main competitor, Boeing, and other aerospace manufacturers to capture market share from airlines seeking to avoid delivery uncertainties.

Cargo Capacity Crisis: Which Stocks May Benefit Most?

Cargo Capacity Crisis: Which Stocks May Benefit Most?

The crash of a UPS cargo plane has led to the grounding of an entire class of aging aircraft across the logistics industry. This creates a potential investment opportunity in competing cargo carriers and aircraft manufacturers poised to fill the resulting gap in shipping capacity.

UK-US Pharma Trade Deal | Tariff-Free Market Access

UK-US Pharma Trade Deal | Tariff-Free Market Access

A new trade deal eliminates tariffs on pharmaceuticals between the UK and the US, strengthening transatlantic trade. This creates a powerful tailwind for pharmaceutical companies in both countries, potentially boosting exports, innovation, and profitability.

Frequently Asked Questions